GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Optomed PLC (OHEL:OPTOMED) » Definitions » Capex-to-Revenue

Optomed (OHEL:OPTOMED) Capex-to-Revenue : 0.19 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Optomed Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Optomed's Capital Expenditure for the three months ended in Mar. 2025 was €-0.78 Mil. Its Revenue for the three months ended in Mar. 2025 was €4.02 Mil.

Hence, Optomed's Capex-to-Revenue for the three months ended in Mar. 2025 was 0.19.


Optomed Capex-to-Revenue Historical Data

The historical data trend for Optomed's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optomed Capex-to-Revenue Chart

Optomed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.17 0.21 0.16 0.14

Optomed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.15 0.13 0.12 0.19

Competitive Comparison of Optomed's Capex-to-Revenue

For the Health Information Services subindustry, Optomed's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optomed's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Optomed's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Optomed's Capex-to-Revenue falls into.


;
;

Optomed Capex-to-Revenue Calculation

Optomed's Capex-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.118) / 15.04
=0.14

Optomed's Capex-to-Revenue for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.781) / 4.021
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optomed  (OHEL:OPTOMED) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Optomed Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Optomed's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Optomed Business Description

Traded in Other Exchanges
Address
Yrttipellontie 1, Oulu, FIN, 90230
Optomed PLC is a Finnish medical technology company and a manufacturer of handheld fundus cameras and screening software. The company operates in two business segments which are Devices and Software. Devices segment develops, commercializes, and manufactures easy-to-use and affordable handheld fundus cameras, that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, glaucoma, and AMD. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company operates in Finland, China, and other countries.

Optomed Headlines

No Headlines